KR102232659B9 - Fc- polypepide for delivery of antigen Fc-fusion protein comprising thereof and use thereof - Google Patents

Fc- polypepide for delivery of antigen Fc-fusion protein comprising thereof and use thereof

Info

Publication number
KR102232659B9
KR102232659B9 KR1020180082238A KR20180082238A KR102232659B9 KR 102232659 B9 KR102232659 B9 KR 102232659B9 KR 1020180082238 A KR1020180082238 A KR 1020180082238A KR 20180082238 A KR20180082238 A KR 20180082238A KR 102232659 B9 KR102232659 B9 KR 102232659B9
Authority
KR
South Korea
Prior art keywords
polypepide
antigen
delivery
fusion protein
fusion
Prior art date
Application number
KR1020180082238A
Other languages
Korean (ko)
Other versions
KR20200008288A (en
KR102232659B1 (en
Inventor
양문식
장용석
김미영
마 줄리안
렐리취 라이코
반 돌리워드 크레이그
Original Assignee
전북대학교 산학협력단
세인트 조지'스, 유니버시티 오브 런던
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교 산학협력단, 세인트 조지'스, 유니버시티 오브 런던 filed Critical 전북대학교 산학협력단
Priority to KR1020180082238A priority Critical patent/KR102232659B1/en
Publication of KR20200008288A publication Critical patent/KR20200008288A/en
Application granted granted Critical
Publication of KR102232659B1 publication Critical patent/KR102232659B1/en
Publication of KR102232659B9 publication Critical patent/KR102232659B9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/522—CH1 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020180082238A 2018-07-16 2018-07-16 polypepide for delivery of antigen, Fc-fusion protein comprising thereof and use thereof KR102232659B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180082238A KR102232659B1 (en) 2018-07-16 2018-07-16 polypepide for delivery of antigen, Fc-fusion protein comprising thereof and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180082238A KR102232659B1 (en) 2018-07-16 2018-07-16 polypepide for delivery of antigen, Fc-fusion protein comprising thereof and use thereof

Publications (3)

Publication Number Publication Date
KR20200008288A KR20200008288A (en) 2020-01-28
KR102232659B1 KR102232659B1 (en) 2021-03-26
KR102232659B9 true KR102232659B9 (en) 2022-03-15

Family

ID=69370589

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180082238A KR102232659B1 (en) 2018-07-16 2018-07-16 polypepide for delivery of antigen, Fc-fusion protein comprising thereof and use thereof

Country Status (1)

Country Link
KR (1) KR102232659B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050094819A (en) * 2002-12-20 2005-09-28 바이오겐 아이덱 엠에이 인코포레이티드 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
WO2014022592A1 (en) * 2012-08-02 2014-02-06 Jn Biosciences Llc Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
KR20160130463A (en) * 2014-03-05 2016-11-11 유씨비 바이오파마 에스피알엘 Multimeric fc proteins

Also Published As

Publication number Publication date
KR20200008288A (en) 2020-01-28
KR102232659B1 (en) 2021-03-26

Similar Documents

Publication Publication Date Title
IL276464A (en) Methods and compositions for therapeutic protein delivery
IL281783A (en) Sirpα binding proteins and methods of use thereof
IL276731A (en) Anti-cd73 antibodies and methods of use thereof
IL276715A (en) Compositions and methods for membrane protein delivery
EP3623388A4 (en) Bispecific recombinant protein and use thereof
IL278821A (en) Anti-sirpa antibodies and methods of use thereof
IL280102A (en) Pd1-4-1bbl variant fusion protein and methods of use thereof
IL274434A (en) Immunogenic heteroclitic peptides from cancer-associated proteins and methods of use thereof
ZA202006066B (en) Anti-hla-g antibodies and use thereof
IL270214A (en) Anti-sortilin antibodies and methods of use thereof
EP3490538A4 (en) Particles for delivery of proteins and peptides
EP3518971A4 (en) Antibody and protein therapeutic formulations and uses thereof
IL280103A (en) Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
IL284156A (en) Anti-ctla-4 binding proteins and methods of use thereof
IL279648A (en) Anti-sirp-beta1 antibodies and methods of use thereof
ZA202101250B (en) Novel crispr-associated protein and use thereof
SG11202104912SA (en) Fusion protein and use thereof
IL279353A (en) Use of antibody / tgf-β protein for treatment of nsclc
IL283884A (en) Anti-il-36 antibodies and methods of use thereof
IL280338A (en) Anti-siglec-5 antibodies and methods of use thereof
IL283830A (en) Multigene construct for immune-modulatory protein expression and methods of use
EP3615060A4 (en) Hsv antigenic peptides and hsv protein vaccines
IL279227A (en) Anti-siglec-7 antibodies and methods of use thereof
KR102232659B9 (en) Fc- polypepide for delivery of antigen Fc-fusion protein comprising thereof and use thereof
IL280450A (en) Cdca1-derived peptide and vaccine containing same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]